Synonym: 1,1′-(1,10-decanediyl)bis[3-methyl-pyridinium iodide (1:2) hydrate; N,N-decane-1,10-diyl-bis-3-picolinium diiodide hydrate
CAS Number: 525596-64-9 (anhydrous)
Empirical Formula (Hill Notation): C22H34I2N2 · xH2O
Molecular Weight: 580.33 (anhydrous basis)
MDL Number: MFCD21608520
Linear Formula: C22H34I2N2 · xH2O
Product Type: Chemical
assay |
≥98% (HPLC) |
color |
white to tan |
form |
powder |
InChI |
1S/C22H34N2.2HI.H2O/c1-21-13-11-17-23(19-21)15-9-7-5-3-4-6-8-10-16-24-18-12-14-22(2)20-24;;;/h11-14,17-20H,3-10,15-16H2,1-2H3;2*1H;1H2/q+2;;;/p-2 |
InChI key |
ILAREMIWZYIULF-UHFFFAOYSA-L |
Quality Level |
100 ![External link](https://krackeler.com/images/sigma/ext-link.gif) |
SMILES string |
O.[I-].[I-].Cc1ccc[n+](CCCCCCCCCC[n+]2cccc(C)c2)c1 |
solubility |
H2O: ≥10 mg/mL |
storage temp. |
2-8°C |
Application: |
bPiDl hydrate may be used to study nicotinic receptor-mediated signaling. |
Biochem/physiol Actions: |
bPiDI is an α6β2-specific antagonist that inhibits nicotine-evoked and endogenous dopamine release from rat striatal slices (IC50 = 150 nM, Imax = 55%). bPiDI treatment decreases nicotine self-administration, and nicotine-induced locomotor activity in rats. |
Features and Benefits: |
This compound is featured on the Acetylcholine Receptors (Nicotinic) page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
Packaging: |
10 mg in glass bottle |
RIDADR |
NONH for all modes of transport |
WGK Germany |
WGK 3 |
Flash Point(F) |
Not applicable |
Flash Point(C) |
Not applicable |
Purity |
≥98% (HPLC) |
Storage Temp. |
2-8°C |
UNSPSC |
12352200 |